The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

This self-helper virus is an inhibited version of ASFV which has been modified using CRISPR/Cas9 technology, a powerful ...

Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock ...

One of the key challenges of the modern genomics era is studying the thousands of genes in a single human cell at scale. To ...

Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that its Chief Operating Officer, Julianne ...

This study achieved CRISPR/Cas9-mediated genome editing in grass carp (Ctenopharyngodon idella), China's most economically vital freshwater fish. Targeting the tyrb gene critical for pigmentation were ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...